Paul C Grimm
Overview
Explore the profile of Paul C Grimm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahan R, Abraham N, Lee H, Ettenger R, Grimm P, Reed E, et al.
Pediatr Transplant
. 2024 Nov;
28(8):e14877.
PMID: 39508125
Background: Natural killer (NK) cells have gained recognition for playing an integral role in both alloimmunity and protective immunity, particularly viral infection control, in solid organ transplantation. Using data from...
2.
Razdan S, Davis A, Tidmarsh G, Hintz S, Grimm P, Chock V
Pediatrics
. 2023 Dec;
153(1).
PMID: 38098437
Infants with congenital bilateral renal agenesis are at significant risk for morbidity and mortality, despite substantial and continuing advances in fetal and neonatal therapeutics. Infants with bilateral renal agenesis may...
3.
Bertaina A, Grimm P, Weinberg K
N Engl J Med
. 2022 Sep;
387(9):860.
PMID: 36053526
No abstract available.
4.
Sigurjonsdottir V, Purington N, Chaudhuri A, Zhang B, Fernandez-Vina M, Palsson R, et al.
Transpl Int
. 2022 Aug;
35:10158.
PMID: 35992747
Antibody-mediated rejection is a common cause of early kidney allograft loss but the specifics of antibody measurement, therapies and endpoints have not been universally defined. In this retrospective study, we...
5.
6.
Piburn K, Sigurjonsdottir V, Indridason O, Maestretti L, Patton M, McGrath A, et al.
Clin J Am Soc Nephrol
. 2022 Jul;
17(8):1194-1203.
PMID: 35882506
Background And Objectives: High tacrolimus intrapatient variability has been associated with inferior graft outcomes in patients with kidney transplants. We studied baseline patterns of tacrolimus intrapatient variability in pediatric patients...
7.
Bertaina A, Grimm P, Weinberg K, Parkman R, Kristovich K, Barbarito G, et al.
N Engl J Med
. 2022 Jun;
386(24):2295-2302.
PMID: 35704481
Lifelong immunosuppression is required for allograft survival after kidney transplantation but may not ultimately prevent allograft loss resulting from chronic rejection. We developed an approach that attempts to abrogate immune...
8.
Sigurjonsdottir V, Maestretti L, McGrath A, Concepcion W, Gallo A, Jonsdottir U, et al.
Pediatr Nephrol
. 2022 Jan;
37(9):2091-2098.
PMID: 35006359
Background: Currently, there is no consensus among pediatric kidney transplant centers regarding the use and regimen for immunosuppressive induction therapy. Methods: In this single center, retrospective cohort study, pediatric kidney...
9.
Kumar J, Contrepois K, Snyder M, Grimm P, Moudgil A, Smith J, et al.
Transplant Direct
. 2021 Nov;
7(12):e791.
PMID: 34805493
Methods: Validating Injury to the Renal Transplant Using Urinary Signatures Children's Study, a North American multicenter prospective cohort study of pediatric kidney transplant recipients, aims to validate urinary cell mRNA...
10.
Krissberg J, Kaufmann M, Gupta A, Bendavid E, Stedman M, Cheng X, et al.
Clin J Am Soc Nephrol
. 2021 Oct;
16(12):1862-1871.
PMID: 34670797
Background And Objectives: In December 2014, the Kidney Allocation System (KAS) was implemented to improve equity in access to transplantation, but preliminary studies in children show mixed results. Thus, we...